期刊文献+

蛛网膜下腔出血后继发脑血管痉挛的早期诊断与外科治疗 被引量:1

下载PDF
导出
摘要 目的探讨早期外科治疗蛛网膜下腔出血后继发脑血管痉挛(CVS)的合理有效方法。方法采用早期显微手术动脉瘤颈夹闭术18例,在清除血肿和成功夹闭动脉瘤后局部使用罂粟碱治疗脑血管痉挛。微弹簧圈血管内栓塞2例,超选择性动脉内灌注罂粟碱。结果早期外科治疗蛛网膜下腔出血后继发脑血管痉挛总有效率95%。结论早期外科治疗蛛网膜下腔出血后继发脑血管痉挛可使病人临床症状和神经功能恶化得到明显改善,对提高病人病情预后有一定的实际意义。
作者 李涛 郝解贺
出处 《中西医结合心脑血管病杂志》 2008年第6期736-738,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献12

  • 1王新德.神经系统血管性疾病[M].北京:人民军医出版社,2001.156.
  • 2Bebjamin S.阿尔茨海默病(Alzheimer’s Disease)的药物治疗[M].北京:科学技术文献出版社,2000:35-53.
  • 3刘芳龄,刘多三,饶明俐,郝晓淑,田玉旺.实验性迟发性脑血管痉挛时痉挛动脉的自由基代谢[J].中国神经精神疾病杂志,1996,22(4):215-217. 被引量:7
  • 4Stern Y, Sano M, Mayeux R. Long- term administration of physostigmine in Alzheimer' s disease[ J ]. Neurology, 1988,38 : 1387.
  • 5Schneider LS, Farlow M, Henderson VW, et al. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer' s disease[ J ]. Neurology, 1996,46 : 1580 - 1584.
  • 6Packer L, Haranaki N, Kawabata T, et al. Ginkgo biloba extract (Egb761) [ M ]//Christen Y, Coutois Y, Droy MJ. Effects of Ginkgo biloba Extract ( Egb761 ) on aging and Age - related Disordersed.Paris: Editions Scientifiques Elsevier, 1995 : 23 - 47.
  • 7解旭东,汪明慧,冀风云.蛛网膜下腔出血后脑血管痉挛治疗的研究进展[J].医学综述,2001,7(10):599-600. 被引量:12
  • 8Cummings JL, Cyrus PA, Bieber F, et al. Metrifonate treatment of the cognitive deficits of Alzheimer' s disease [ J]. Neurology, 1998, 50 : 1214 - 1221.
  • 9CummingsJL, Vinters HV, Cole GM, et al . Alzheimer ' s disease : Etiologies, pathophysiology, cognitive reserve, and treatment opportunities[J ]. Neurology, 1998, 51 (suppl 1 ) : S2 - S17.
  • 10Kaufer DI, Cummings JL, Christine D. Effects of tacrine on behavioral symptoms in Alzheimer' s disease: An open - label study [ J ]. J Geriatr Psychiatry Neurol, 1996,9:1 - 6.

二级参考文献18

  • 1[1]Lennihan L,Mayer SA,Fink ME,et al.Effect of hypervolemic therapy on cerebral blood flow after subarachnoid haemorrhage:a randomized controlled trial.Stroke,2000,31(2):383-391
  • 2[2]Firlik AD,Kaufmann AM,Jungreis CA,Yonas H.Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage.J Neurosurg,1997,86(5):830-839
  • 3[3]Fujiwara N,Honjo Y,Ohkawa M,et al.Effectiveness of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for symptomatic vasospasm after subarachnoid hemorrhage.Nippon Igaku Hoshasen Gakkai Zasshi,1997,57(7):412-417
  • 4[4]Minato H,Hashizume M,Masuda Y,et al.Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6,11 -dihydrodibenz[ b,e ] oxepin-11-yl) -4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerbral arteries of rabbit and dog.Arzneimittelforschung,1997,47 (4):339-346
  • 5[5]Roux S,Breu V,Giller T,et al.Ro 61-1790,a new hydrosoluble endothelin antagonist:general pharmacology and effects on experimental cerebral vasospasm.J Pharmacol Exp Ther,1997,283(3):1110-1118
  • 6[6]Zimmermann M.Endothelin in cerebral vaspasm.Clinical and experimental results.J Neurosurg Sci,1997,41(2):139-151
  • 7[7]Kwan AL,Bavbek M,Jeng AY,et al.Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor,CGS26303,in an experimental model of subarachnoid hemorrhage,J Neurosurg,1997,87(2):281-286
  • 8[8]Mima T,Mostafa MG,Mori K.Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerbral vasospasm after subarachnoid hemorrhage.Acta Neurochir[ Suppl ] (Wien),1997,70(1):65-67
  • 9[9]Yamamoto S,Nishizawa S,Yokoyama T,et al.Subarachnoid hemorrhage impairs cerbral blood flow response to nitric oxide but not to cyclic GMP in large cerbral arteries.Brain Res,1997,757(1):1-9
  • 10[10]Khajavi K,Ayzman I,Shearer D,et al.Prevention of chronic cerebral vasospasm in dogs with milrinone.Neurosurgery,1997,40(2):354-362

共引文献121

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部